IPATASERTIB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where IPATASERTIB was used for Prostate cancer.
Most Reported Side Effects for IPATASERTIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 17 | 13.6% | 4 | 11 |
| Pyrexia | 11 | 8.8% | 0 | 10 |
| Fatigue | 10 | 8.0% | 1 | 5 |
| Hyperglycaemia | 9 | 7.2% | 3 | 5 |
| Rash | 8 | 6.4% | 2 | 4 |
| Nausea | 7 | 5.6% | 2 | 2 |
| Vomiting | 7 | 5.6% | 2 | 3 |
| Acute kidney injury | 6 | 4.8% | 0 | 6 |
| Pneumonitis | 6 | 4.8% | 1 | 2 |
| Rash maculo-papular | 6 | 4.8% | 0 | 4 |
| Anaemia | 5 | 4.0% | 2 | 2 |
| Dehydration | 5 | 4.0% | 0 | 5 |
| Drug ineffective | 5 | 4.0% | 0 | 1 |
Other Indications for IPATASERTIB
Triple negative breast cancer (26)
Breast cancer (17)
Hormone-refractory prostate cancer (14)
Breast cancer metastatic (9)
Prostate cancer metastatic (8)
Her2 negative breast cancer (7)
Neoplasm (7)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)